Canadian Journal of Gastroenterology and Hepatology / 2016 / Article / Tab 2

Research Article

Esophageal Intramural Pseudodiverticulosis and Concomitant Eosinophilic Esophagitis: A Case Series

Table 2

The clinical course, therapeutic interventions, and outcomes for all patients, including subgroup analysis of patients with EIPD and with EoE and pseudodiverticulosis.

CharacteristicsAll patients ()Patients with EIPD ()Patients with EoE and pseudodiverticulosis () value

Total duration of follow-up (months), mean (SD)44.4 (38.1) 52.2 (42.6)27.8 (20.0)0.360

Endoscopic treatment
 Dilatation (balloon, bougienage), (%) 9 (56.3)7 (63.6) 2 (40.0)0.596
 Balloon dilatation, (%) 1 (6.3)1 (9.1)0 (0)NS
 Bougienage, (%) 7 (43.8) 6 (54.5)1 (20.0)0.308
 Total number of endoscopic dilatations, mean (SD)2.7 (2.5)1.67 (1.2)3.0 (2.8)0.643

Mortality
 Deaths, (%)1 (6.3) 1 (9.1)0 (0)NS

EIPD: esophageal intramural pseudodiverticulosis; EoE: eosinophilic esophagitis; SD: standard deviation; NS: not significant.
Mean value calculated only for patients receiving endoscopic dilatations.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.